Anti-Anaerobic Antibiotics, Gut Microbiota, and Sepsis-associated Acute Kidney Injury

Katherine M Winner1, Rishi Chanderraj2, Mark Nuppnau2

  • 1University of Michigan Health System, Internal Medicine, Ann Arbor, Michigan, United States.

Abstract

Insights

Anti-anaerobic antibiotics increase the risk of acute kidney injury (AKI) in sepsis patients by disrupting the gut microbiome. This finding highlights potential mechanisms linking antibiotic use to sepsis complications.

Area of Science:

  • Microbiology
  • Nephrology
  • Pharmacology

Background:

  • Sepsis frequently leads to acute kidney injury (AKI).
  • Anti-anaerobic antibiotics are commonly used in sepsis management and alter the gut microbiome.
  • Previous studies suggest a link between anti-anaerobic antibiotics and mortality, but the underlying mechanisms are unclear.

Purpose of the Study:

  • To investigate if anti-anaerobic antibiotics and gut microbiome changes increase susceptibility to sepsis-associated AKI.
  • To explore the relationship between specific gut bacteria and AKI development in sepsis.

Main Methods:

  • Retrospective cohort study of 12,776 sepsis patients to assess AKI incidence with early anti-anaerobic antibiotic exposure.
  • Instrumental variable analyses using a piperacillin-tazobactam shortage to evaluate the impact on AKI onset and resolution.
  • Matched case-control study of gut microbiota in 372 sepsis patients.
  • Murine model of sepsis to correlate creatinine elevation with gut microbiota composition.

Main Results:

  • Early anti-anaerobic antibiotic use was linked to a 61% increased risk of sepsis-associated AKI.
  • Anti-anaerobic antibiotic treatment (piperacillin-tazobactam) was associated with higher AKI onset hazard and reduced AKI resolution.
  • Increased gut bacterial density and specific bacterial families (Enterobacteriaceae, Lachnospiraceae) predicted AKI onset in sepsis patients.
  • In mice, gut microbiota composition, particularly Lachnospiraceae, significantly correlated with creatinine elevation.

Conclusions:

  • Anti-anaerobic antibiotics are associated with an elevated risk of AKI in sepsis.
  • Gut microbiome modulation by anti-anaerobic antibiotics may be a key mechanism driving sepsis-associated AKI.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
81
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
76
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
41
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
53